High-yield points
- CPC adds benefit under 1 year: Warf found 66% success with ETV-CPC vs 47% with ETV alone. There was no difference at ≥1 year (80% for each) .
- Biggest gains by etiology: myelomeningocele (76% vs 35%) and non-postinfectious hydrocephalus (70% vs 38%). The difference in postinfectious hydrocephalus was not significant .
- Myelomeningocele: 76% success. 86% of failures happened before 6 months and none after 10 months. Cistern or choroid plexus scarring predicted failure; age did not . Pooled MMC data show 75% for ETV-CPC vs 48% for ETV alone .
- Uganda RCT, postinfectious hydrocephalus: ETV-CPC and shunting were equivalent at 1, 2 and 5 years for development, treatment failure and brain volume . Brain growth stalled in the 2nd year in both arms .
- Pooled success: 59% overall in 1,918 infants . By etiology: aqueductal stenosis 71%, myelomeningocele 70%, postinfectious 64%, posthemorrhagic 52% .
- Setting matters: pooled success was 71% in sub-Saharan Africa vs 49% in North America .
- HCRN prospective study: 36% success at 6 months. ETV-CPC failed more often than shunting in matched infants. Complications included seizures (5.1%) and CSF leak (3.4%) .
- HCRN predictors of failure: age <1 month (aHR 1.9) and post-IVH of prematurity (aHR 2.0) .
- Predictors of success: older age, smaller ventricles and greater extent of CPC . Failure HR was 4.4 with <90% CPC, a borderline result (95% CI 1.0–19.2, p = 0.05) .
- ETVSS: validated for ETV alone, not ETV-CPC .
Landmark papers
- Warf (Warf, J Neurosurg 2005): a prospective study of 550 African children. In infants under one year, ETV-CPC succeeded in 66% vs 47% with ETV alone, with no difference at 1 year or older .
- Uganda randomized trial (Kulkarni et al., N Engl J Med 2017): 100 Ugandan infants with postinfectious hydrocephalus were assigned to ETV-CPC or a ventriculoperitoneal shunt. There was no significant difference in cognitive scores, treatment failure or brain volume at 12 months .
- HCRN prospective study (Kulkarni et al., J Neurosurg Pediatr 2018): in North American infants, 6-month success was 36%, and failure was higher than with shunting in matched infants .
Bottom line
Endoscopic third ventriculostomy combined with choroid plexus cauterization (ETV-CPC) is an established way to treat some infants with hydrocephalus without a shunt, but how well it works depends heavily on etiology, age and setting. In Warf's prospective Ugandan series, adding CPC to ETV improved success in infants under one year (66% vs 47%), with the largest benefit in myelomeningocele (76% vs 35%) and non-postinfectious hydrocephalus (70% vs 38%); there was no difference in children one year or older . In a prospective cohort of 115 East African infants with myelomeningocele, ETV-CPC succeeded in 76%, nearly all failures occurred before six months, and scarring of the prepontine cistern or of the choroid plexus predicted failure . In the only randomized trial, 100 Ugandan infants with postinfectious hydrocephalus were assigned to ETV-CPC or a ventriculoperitoneal shunt. The trial found no significant difference in cognitive scores, treatment failure or brain volume at 12 months , at 2 years or at 5 years . Pooled analyses put overall success at about 59–63%, but they rest largely on retrospective series with publication bias. By etiology, success is highest in aqueductal stenosis (71%) and myelomeningocele (70%) and lowest in posthemorrhagic hydrocephalus (52%) . North American results are lower. Pooled North American series reached 49%, compared with 71% in sub-Saharan Africa . In the Hydrocephalus Clinical Research Network's prospective study (HCRN, a multicenter North American research group), 6-month success was 36%, and failure was higher than with shunting in matched infants . A larger HCRN cohort reported 48% success at 6 months and 45% at 18 months. In that cohort, age under one month and hemorrhage-related hydrocephalus of prematurity (post-IVH) independently predicted failure . Success rose with older age, smaller ventricles and a more extensive cauterization , and an earlier HCRN series found a borderline-significant rise in failure with <90% CPC (HR 4.4, p = 0.05) . Formal ETV-CPC training increased complete cauterization but did not independently improve outcomes . The standard ETV Success Score (ETVSS) was developed and recently re-validated in children treated with ETV alone, excluding CPC cases. It has not been validated for ETV-CPC . Overall, ETV-CPC is a reasonable first-line option for selected infants, especially where reliable long-term shunt care isn't available. In North American practice, success depends on careful patient selection and a near-complete cauterization, and it remains well below that of shunting.
Related topics
- Endoscopic Third Ventriculostomy (ETV): ETV alone.
- ETV Success Score Calculator: predicting ETV success.
- Hydrocephalus in Bacterial and Viral Meningitis: postinfectious hydrocephalus.
- Shunt Failure: the alternative to ETV-CPC when it fails.
- Intraventricular Hemorrhage of Prematurity and Posthemorrhagic Hydrocephalus: posthemorrhagic hydrocephalus in preterm infants.
- Ventriculoperitoneal Shunt Insertion: the alternative to ETV-CPC.
References
- Warf BC. Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infants younger than 1 year of age: a prospective study in 550 African children. J Neurosurg 2005;103(6 Suppl):475–481. doi:10.3171/ped.2005.103.6.0475. PMID 16383244. verified
- Warf BC, Campbell JW. Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants. J Neurosurg Pediatr 2008;2(5):310–316. doi:10.3171/PED.2008.2.11.310. PMID 18976099. verified
- Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, et al. Endoscopic treatment versus shunting for infant hydrocephalus in Uganda. N Engl J Med 2017;377(25):2456–2464. doi:10.1056/NEJMoa1707568. PMID 29262276. verified
- Schiff SJ, Kulkarni AV, Mbabazi-Kabachelor E, et al. Brain growth after surgical treatment for infant postinfectious hydrocephalus in Sub-Saharan Africa: 2-year results of a randomized trial. J Neurosurg Pediatr 2021;28(3):326–334. doi:10.3171/2021.2.PEDS20949. PMID 34243157. verified
- Mbabazi-Kabachelor E, Peterson MR, Mugamba J, et al. Five-year outcomes after surgical treatment of infant postinfectious hydrocephalus in sub-Saharan Africa: results of a randomized trial. J Neurosurg Pediatr 2025;36(2):135–144. doi:10.3171/2025.1.PEDS24417. PMID 40315611. verified
- Weil AG, Westwick H, Wang S, et al. Efficacy and safety of endoscopic third ventriculostomy and choroid plexus cauterization for infantile hydrocephalus: a systematic review and meta-analysis. Childs Nerv Syst 2016;32(11):2119–2131. doi:10.1007/s00381-016-3236-6. PMID 27613635. verified
- Albalkhi I, et al. Morbidity and etiology-based success rate of combined endoscopic ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis of 1918 infants. Neurosurg Rev 2023;46(1):180. doi:10.1007/s10143-023-02091-4. PMID 37468790. verified
- Kulkarni AV, Riva-Cambrin J, Rozzelle CJ, et al. Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus: a prospective study by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2018;21(3):214–223. doi:10.3171/2017.8.PEDS17217. PMID 29243972. verified
- Riva-Cambrin J, Kestle JRW, Rozzelle CJ, et al. Predictors of success for combined endoscopic third ventriculostomy and choroid plexus cauterization in a North American setting: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2019;24(2):128–138. doi:10.3171/2019.3.PEDS18532. PMID 31151098. verified
- Kulkarni AV, Riva-Cambrin J, Browd SR, et al. Endoscopic third ventriculostomy and choroid plexus cauterization in infants with hydrocephalus: a retrospective Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2014;14(3):224–229. doi:10.3171/2014.6.PEDS13492. PMID 24995823. verified
- Verhey LH, et al. A re-evaluation of the Endoscopic Third Ventriculostomy Success Score: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2024;33(5):417–427. doi:10.3171/2023.12.PEDS23401. PMID 38335514. verified
- Omar AT 2nd, Espiritu AI, Spears J. Endoscopic third ventriculostomy with or without choroid plexus coagulation for myelomeningocele-associated hydrocephalus: systematic review and meta-analysis. J Neurosurg Pediatr 2022;29(4):435–443. doi:10.3171/2021.11.PEDS21505. PMID 35061994. verified
Verification (2026-10-23): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited here was checked against the PubMed abstract. Full texts were not reviewed.